this page is secure

[ARTICLE WITHDRAWN] MicroRNA-223 Promotes Tumor Progression in Lung Cancer A549 Cells via Activation of the NF-κB Signaling Pathway

This article has been taken down at the request of the publisher.

Please contact the publisher for further information.

Authors: Huang, Li; Li, Fang; Deng, Pengbo; Hu, Chengping

Source: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Volume 24, Number 6, 2016, pp. 405-413(9)

Publisher: Cognizant Communication Corporation

DOI: https://doi.org/10.3727/096504016X14685034103437

This work is licensed under a Creative Commons Attribution-NonCommercial NoDerivatives 4.0 International License.

THIS ARTICLE WAS WITHDRAWN BY THE PUBLISHER IN NOVEMBER 2020

No References for this article.

No Supplementary Data.

No Article Media

No Metrics

Keywords: Cell apoptosis; Cell invasion; Cell proliferation; Lung cancer; MicroRNA-223 (miR-223); NF-κB signal pathway

Document Type: Research Article

Affiliations: Department of Respiratory Medicine, Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China

Publication date: October 27, 2016

More about this publication?

Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.
From Volume 23, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics is Open Access under the terms of the Creative Commons CC BY-NC-ND license.